Premium
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma
Author(s) -
BocconGibod Clémentine,
Talbot Alexis,
Le Bras Fabien,
Frenzel Laurent,
Royer Bruno,
Harel Stephanie,
Lombion Naelle,
Belhadj Karim,
Cuccuini Wendy,
Arnulf Bertrand
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16483
Subject(s) - carfilzomib , venetoclax , dexamethasone , multiple myeloma , medicine , oncology , lenalidomide , refractory (planetary science) , cancer research , leukemia , biology , chronic lymphocytic leukemia , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom